Osteoform Launched BB536 Infant Probiotics

Based on its rich probiotic research experience, Osteoform has collaborated with Japan’s Morinaga Milk to study the probiotic nutritional needs of infants during their growth stages. The new product has selected two friendly human strains, namely Bifidobacterium longum BB536 and Bifidobacterium breve M-16V. Utilizing a new standard of highly active probiotics, Osteoform provides the most compatible protection for the newborn to 7-year-old children population. It’s worth of notice that Osteoform BB536 Infant Probiotics offers comprehensive care with 4 preventive and 3 protective effects, which include preventing colds, diarrhea, constipation, and vomiting, as well as combating eczema, allergies, and asthma. (Source: finance.ifeng)

Visit HPA-China’s Information Hub, CLICK HERE